scholarly article | Q13442814 |
P819 | ADS bibcode | 2016PLoSO..1160975N |
P356 | DOI | 10.1371/JOURNAL.PONE.0160975 |
P932 | PMC publication ID | 4981469 |
P698 | PubMed publication ID | 27512997 |
P50 | author | Michal Kolář | Q55602902 |
Silvia T Cardona | Q56849846 | ||
P2093 | author name string | Pavel Drevinek | |
Ruhi A M Bloodworth | |||
Jose Degrossi | |||
Silvina Lubovich | |||
Jaroslav Nunvar | |||
Lucie Kalferstova | |||
P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
MEGA6: Molecular Evolutionary Genetics Analysis version 6.0 | Q24498082 | ||
GenBank | Q24656173 | ||
Velvet: algorithms for de novo short read assembly using de Bruijn graphs | Q24657623 | ||
Structural basis for mannose recognition by a lectin from opportunistic bacteria Burkholderia cenocepacia | Q27649666 | ||
Structural basis of the affinity for oligomannosides and analogs displayed by BC2L-A, a Burkholderia cenocepacia soluble lectin | Q27657504 | ||
Burkholderia cenocepacia BC2L-C Is a Super Lectin with Dual Specificity and Proinflammatory Activity | Q27673736 | ||
Rfam 11.0: 10 years of RNA families | Q28278745 | ||
The multifarious, multireplicon Burkholderia cepacia complex | Q28301994 | ||
Trimmomatic: a flexible trimmer for Illumina sequence data | Q29547278 | ||
Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data | Q29547401 | ||
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 | ||
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools | Q29547623 | ||
Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. | Q30426714 | ||
SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. | Q30573666 | ||
Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum | Q30636019 | ||
Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding L-ornithine N(5)-oxygenase | Q30756809 | ||
Pyrrolnitrin from Burkholderia cepacia: antibiotic activity against fungi and novel activities against streptomycetes | Q32031375 | ||
Multilocus sequence typing breathes life into a microbial metagenome | Q33267279 | ||
Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. | Q33397958 | ||
Reciprocal regulation by the CepIR and CciIR quorum sensing systems in Burkholderia cenocepacia | Q33504433 | ||
Prevalence of indeterminate genetic species of Burkholderia cepacia complex in a cystic fibrosis center in Argentina | Q43077343 | ||
Burkholdines from Burkholderia ambifaria: antifungal agents and possible virulence factors | Q43867476 | ||
The high amino-acid content of sputum from cystic fibrosis patients promotes growth of auxotrophic Pseudomonas aeruginosa | Q45166367 | ||
Production of the antifungal compound pyrrolnitrin is quorum sensing-regulated in members of the Burkholderia cepacia complex. | Q46120601 | ||
Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis | Q47695927 | ||
Identifying the genetic basis of ecologically and biotechnologically useful functions of the bacterium Burkholderia vietnamiensis | Q48080924 | ||
Biosynthesis of an antifungal oligopeptide in Burkholderia contaminans strain MS14. | Q52591596 | ||
'Cepacia syndrome' with Burkholderia multivorans, 9 years after initial colonization. | Q52858667 | ||
AmbR1 is a key transcriptional regulator for production of antifungal activity of Burkholderia contaminans strain MS14 | Q84009539 | ||
Fast and SNP-tolerant detection of complex variants and splicing in short reads | Q33751343 | ||
The changing microbial epidemiology in cystic fibrosis | Q33825634 | ||
Genomic expression analysis reveals strategies of Burkholderia cenocepacia to adapt to cystic fibrosis patients' airways and antimicrobial therapy. | Q34117003 | ||
Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. | Q34140808 | ||
Genetic diversity of Burkholderia contaminans isolates from cystic fibrosis patients in Argentina | Q34310496 | ||
The Streptomyces leeuwenhoekii genome: de novo sequencing and assembly in single contigs of the chromosome, circular plasmid pSLE1 and linear plasmid pSLE2 | Q34482803 | ||
BLAST: a more efficient report with usability improvements | Q34681373 | ||
Software for computing and annotating genomic ranges | Q34945230 | ||
Solving the problem of comparing whole bacterial genomes across different sequencing platforms | Q35222674 | ||
Swimming motility in a longitudinal collection of clinical isolates of Burkholderia cepacia complex bacteria from people with cystic fibrosis. | Q35244339 | ||
Gene expression profiling of Burkholderia cenocepacia at the time of cepacia syndrome: loss of motility as a marker of poor prognosis? | Q35455438 | ||
Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. | Q35536317 | ||
The Rate and Molecular Spectrum of Spontaneous Mutations in the GC-Rich Multichromosome Genome of Burkholderia cenocepacia | Q35882379 | ||
Molecular analysis of Burkholderia cepacia complex isolates from a Portuguese cystic fibrosis center: a 7-year study | Q35922213 | ||
Rate and molecular spectrum of spontaneous mutations in the bacterium Escherichia coli as determined by whole-genome sequencing. | Q36339832 | ||
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients | Q37033480 | ||
The unexpected discovery of a novel low-oxygen-activated locus for the anoxic persistence of Burkholderia cenocepacia | Q37039711 | ||
The Burkholderia Genome Database: facilitating flexible queries and comparative analyses | Q37090715 | ||
Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans | Q37407643 | ||
Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans. | Q37623459 | ||
Genetic variation of a bacterial pathogen within individuals with cystic fibrosis provides a record of selective pressures. | Q37691811 | ||
Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapy | Q37788421 | ||
Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance | Q37794342 | ||
Quorum sensing systems influence Burkholderia cenocepacia virulence | Q38066575 | ||
Spontaneous mutation rates come into focus in Escherichia coli | Q38259429 | ||
Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review. | Q38273318 | ||
Genetic and biochemical map for the biosynthesis of occidiofungin, an antifungal produced by Burkholderia contaminans strain MS14. | Q38283421 | ||
The Burkholderia contaminans MS14 ocfC gene encodes a xylosyltransferase for production of the antifungal occidiofungin. | Q39462535 | ||
A More Sensitive Plate Assay for Detection of Protease Production by Pseudomonas aeruginosa | Q39671771 | ||
Auxotrophy of Burkholderia (Pseudomonas) cepacia from cystic fibrosis patients. | Q40008470 | ||
Identification of quorum sensing-controlled genes in Burkholderia ambifaria. | Q40013939 | ||
Distribution and expression of the ZmpA metalloprotease in the Burkholderia cepacia complex | Q40702312 | ||
Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance. | Q40909070 | ||
Draft Genome Sequences of Burkholderia contaminans, a Burkholderia cepacia Complex Species That Is Increasingly Recovered from Cystic Fibrosis Patients | Q41065020 | ||
Burkholderia cenocepacia ZmpB is a broad-specificity zinc metalloprotease involved in virulence | Q41475202 | ||
Increase in isolation of Burkholderia contaminans from Spanish patients with cystic fibrosis. | Q41498252 | ||
Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection | Q41741069 | ||
A Burkholderia cepacia complex non-ribosomal peptide-synthesized toxin is hemolytic and required for full virulence | Q42013317 | ||
Functional quorum sensing systems are maintained during chronic Burkholderia cepacia complex infections in patients with cystic fibrosis | Q42710647 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | DESeq2 | Q113018293 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cystic fibrosis | Q178194 |
Burkholderia contaminans | Q16849219 | ||
emerging pathogen | Q108429945 | ||
P304 | page(s) | e0160975 | |
P577 | publication date | 2016-08-11 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Understanding the Pathogenicity of Burkholderia contaminans, an Emerging Pathogen in Cystic Fibrosis | |
P478 | volume | 11 |
Q52728418 | Biocontrol of Burkholderia cepacia complex bacteria and bacterial phytopathogens by Bdellovibrio bacteriovorus. |
Q39010188 | Burkholderia cepacia Complex Regulation of Virulence Gene Expression: A Review |
Q92652695 | Burkholderia cepacia Complex Species Differ in the Frequency of Variation of the Lipopolysaccharide O-Antigen Expression During Cystic Fibrosis Chronic Respiratory Infection |
Q52374209 | Chronic Azithromycin Use in Cystic Fibrosis and Risk of Treatment-Emergent Respiratory Pathogens. |
Q38686249 | Class III Histidine Kinases: a Recently Accessorized Kinase Domain in Putative Modulators of Type IV Pilus-Based Motility |
Q92233675 | Cyclopropanol Warhead in Malleicyprol Confers Virulence of Human- and Animal-Pathogenic Burkholderia Species |
Q89778047 | Genomic and phenotypic characterization of Burkholderia isolates from the potable water system of the International Space Station |
Q92977261 | Impact of clonally-related Burkholderia contaminans strains in two patients attending an Italian cystic fibrosis centre: a case report |
Q39454020 | Mass spectrometric techniques for the analysis of volatile organic compounds emitted from bacteria. |
Q91731981 | Whole Genome Sequence Analysis of Burkholderia contaminans FFH2055 Strain Reveals the Presence of Putative β-Lactamases |
Search more.